BioPharma Credit PLC
BOPCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 70.3% | -42.7% | 38.3% | – |
| Cost of Goods Sold | $0 | -$0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 108.6% | 127% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | -$0 | $0 | $0 |
| SG&A Expenses | $0 | -$0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 94.1% | 110.9% | 90.9% | 65.6% |
| Other Income/Exp. Net | $0 | $0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 94.3% | 111.1% | 90.8% | 65.6% |
| EPS | 0.063 | 0.042 | 0.058 | 0.029 |
| % Growth | 50.7% | -27.2% | 100.3% | – |
| EPS Diluted | 0.063 | 0.042 | 0.058 | 0.029 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$0 | $0 | -$0 | -$0 |
| EBITDA | $0 | -$0 | $0 | -$0 |
| % Margin | 0% | -158.5% | 90.8% | -0% |